Skip to main content
Clinical Trials/NCT03554590
NCT03554590UnknownNot Applicable

Effectiveness of Carbohydrate Counting on Glycaemic Control in T1DM Patients

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 site in 1 country50 target enrollmentStarted: December 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
50
Locations
1
Primary Endpoint
glycemic control

Study Overview

Brief Summary

Carbohydrate counting is the most effective meal-planning strategy in type 1 diabetes (T1DM) to optimize insulin therapy. However, it may lead to weight gain and unhealthy eating habits. This study aims to compare glycemic control parameters, anthropometric measurements and dietary lifestyle in T1DM patients who practice CHO-counting, after attending a structured course to learn how to manage this tecnique, vs a control Group, in a follow up period of 2 years.

Detailed Description

patients with type 1 DM will be enrolled in the study. patients in the intervention group will attend a 5-lessons training to learn how to manage insulin therapy depending on the amount of carbohydrates in their meals, patients in the control group will be follow according to the the standard care. after the follow up period glycometabolic, anthropometric parameters and dietary lifestyle changes will be compared between the two groups.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •type 1 diabetes mellitus
  • •insulin therapy
  • •HbA1c from 5.5 to 10%

Exclusion Criteria

  • •pregnancy
  • •celiac disease
  • •hepatic impairment
  • •chronic renal failure

Arms & Interventions

carbo-counters

Experimental

carbohydrate counting: patients attending a structured carbohydrate-counting training and practicing this tecnique to manage insulin therapy

Intervention: carbohydrate counting (Behavioral)

control group

Active Comparator

insulin therapy according to standard care. patients who don't practice carbohydrate-counting to manage insulin therapy

Intervention: insulin therapy according to standard care (Behavioral)

Outcomes

Primary Outcomes

glycemic control

Time Frame: 2 years

HbA1c

Secondary Outcomes

  • dietary lifestyle(2 years)
  • glucose variability: mean and standard deviation of self monitoring blood glucose (SMBG)(2 YEARS)
  • glucose variability: incidence of hypoglycaemia(2 YEARS)
  • anthropometric parameters: BMI(2 years)
  • anthropometric parameters: WAIST AND HIP CIRCUMFERENCE(2 years)
  • anthropometric parameters: BIOIMPEDENTIOMETRIC PARAMETERS(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Emanuela Orsi

Head of DIabetology

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Study Sites (1)

Loading locations...

Similar Trials